Coregulation of alternative splicing by hnRNPM and ESRP1 during EMT.
Coregulation of alternative splicing by hnRNPM and ESRP1 during EMT.
复制标题
DOI:
10.1261/rna.066712.118
复制
发表时间:
2018-10
期刊:
影响因子:
--
通讯作者:
Cheng C
中科院分区:
文献类型:
--
作者:
Harvey SE;Xu Y;Lin X;Gao XD;Qiu Y;Ahn J;Xiao X;Cheng C
The epithelial–mesenchymal transition (EMT) is a fundamental developmental process that is abnormally activated in cancer metastasis. Dynamic changes in alternative splicing occur during EMT. ESRP1 and hnRNPM are splicing regulators that promote an epithelial splicing program and a mesenchymal splicing program, respectively. The functional relationships between these splicing factors in the genome scale remain elusive. Comparing alternative splicing targets of hnRNPM and ESRP1 revealed that they coregulate a set of cassette exon events, with the majority showing discordant splicing regulation. Discordant splicing events regulated by hnRNPM show a positive correlation with splicing during EMT; however, concordant events do not, indicating the role of hnRNPM in regulating alternative splicing during EMT is more complex than previously understood. Motif enrichment analysis near hnRNPM–ESRP1 coregulated exons identifies guanine–uridine rich motifs downstream from hnRNPM-repressed and ESRP1-enhanced exons, supporting a general model of competitive binding to these cis-elements to antagonize alternative splicing. The set of coregulated exons are enriched in genes associated with cell migration and cytoskeletal reorganization, which are pathways associated with EMT. Splicing levels of coregulated exons are associated with breast cancer patient survival and correlate with gene sets involved in EMT and breast cancer subtyping. This study identifies complex modes of interaction between hnRNPM and ESRP1 in regulation of splicing in disease-relevant contexts.
登录
查看更多内容
影响因子:
7.3
作者:
Liu, Sali;Cheng, Chonghui
通讯作者:
Cheng, Chonghui
影响因子:
7
作者:
Harrow J;Frankish A;Gonzalez JM;Tapanari E;Diekhans M;Kokocinski F;Aken BL;Barrell D;Zadissa A;Searle S;Barnes I;Bignell A;Boychenko V;Hunt T;Kay M;Mukherjee G;Rajan J;Despacio-Reyes G;Saunders G;Steward C;Harte R;Lin M;Howald C;Tanzer A;Derrien T;Chrast J;Walters N;Balasubramanian S;Pei B;Tress M;Rodriguez JM;Ezkurdia I;van Baren J;Brent M;Haussler D;Kellis M;Valencia A;Reymond A;Gerstein M;Guigó R;Hubbard TJ
通讯作者:
Hubbard TJ
影响因子:
5.3
作者:
Dittmar, Kimberly A.;Jiang, Peng;Carstens, Russell P.
通讯作者:
Carstens, Russell P.
DOI:
10.1007/s12032-015-0593-z
发表时间:
2015-05
期刊:
Medical oncology (Northwood, London, England)
影响因子:
--
作者:
Hernandez JR;Kim JJ;Verdone JE;Liu X;Torga G;Pienta KJ;Mooney SM
通讯作者:
Mooney SM
影响因子:
15.9
作者:
Brown, Rhonda L.;Reinke, Lauren M.;Cheng, Chonghui
通讯作者:
Cheng, Chonghui